Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Neuroone Medical Technologies (NMTC) Return on Assets (2016 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Return on Assets for 11 consecutive years, with 0.71% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets rose 51.0% year-over-year to 0.71%, compared with a TTM value of 0.71% through Dec 2025, up 51.0%, and an annual FY2025 reading of 0.45%, up 138.0% over the prior year.
  • Return on Assets was 0.71% for Q4 2025 at Neuroone Medical Technologies, down from 0.33% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.33% in Q3 2025 and bottomed at 2.4% in Q3 2024.
  • Average Return on Assets over 5 years is 1.19%, with a median of 1.0% recorded in 2022.
  • The sharpest move saw Return on Assets crashed -117bps in 2024, then surged 206bps in 2025.
  • Year by year, Return on Assets stood at 0.86% in 2021, then grew by 8bps to 0.79% in 2022, then tumbled by -144bps to 1.94% in 2023, then surged by 37bps to 1.21% in 2024, then skyrocketed by 42bps to 0.71% in 2025.
  • Business Quant data shows Return on Assets for NMTC at 0.71% in Q4 2025, 0.33% in Q3 2025, and 0.7% in Q2 2025.